First clinical scan using XENOVIEW™ conducted at Cincinnati Children’s Hospital Medical Center Posted on May 11, 2023 by Brady Anna
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit Posted on May 3, 2023 by Brady Anna
FDA Grants New Chemical Entity designation for XENOVIEW™ (xenon Xe 129 hyperpolarized) Posted on February 14, 2023February 16, 2023 by Brady Anna
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) Posted on December 28, 2022January 26, 2023 by Brady Anna
Complete Response Letter Received from FDA Posted on October 6, 2021January 26, 2023 by Amanda Monroe
Polarean Announces NDA Submission of 129Xenon Gas MRI Posted on October 7, 2020January 26, 2023 by Amanda Monroe
